The FAA has determined that pilots may receive Moderna’s COVID-19 vaccine under the conditions of their FAA-issued airman medical certification. FAA Air Traffic Controllers, who are subject to FAA medical clearance, have also been cleared to receive the vaccination.

Similar to the guidance provided for Pfizer, Inc.’s version of the vaccine, the agency will require pilots with medical certifications or air traffic controllers with medical clearances to observe a period of 48 hours following the administration of each dose of this vaccine before conducting safety-sensitive aviation duties.

The required waiting period applies to those holding an Airman Medical Certificate issued under 14 CFR Part 67 or a Medical Clearance issued under FAA Order 3930.3C.

Because the Moderna vaccine also requires two doses, this time 28 days apart, the waiting period applies after each dose.

NATA will hold a series of webinars in January providing guidance and intelligence from medical and human resource perspectives. Don’t miss your chance to get your questions answered.

For general press inquiries, contact Shannon Chambers at 703-298-1347 or schambers@nata.aero. 

The National Air Transportation Association (NATA) has been the voice of aviation business for more than 80 years. Representing nearly 3,700 aviation businesses, NATA’s member companies provide a broad range of services to general aviation, the airlines and the military and NATA serves as the public policy group representing the interests of aviation businesses before Congress and the federal agencies.